Overview
Employees
51-200 employees
Revenue
$25 to $50 million (USD) per year
Competitors
Stryker, LifeCell, Lifenet
Headquarters
Baltimore, Maryland
KeraLink International is working to reverse corneal blindness globally. Founded in 1962 as the Medical Eye Bank of Maryland, KeraLink’s mission has always been committed to restoring sight. Following the sale of its U.S. eye banking assets in 2019, KeraLink is now solely focused on revolutionizing corneal transplantation to make sight-restoring treatment available in low and middle income countries, where most of the unmet need exists. KeraLink International, Inc. operates as a non-profit organization. The Organization provides ocular tissue for transplantation, education, and research, as well as specializes in corneal transplantation and supplies. KeraLink International serves communities worldwide.
